NHS says no to new breast cancer drug Kadcyla

The drug - Kadcyla - adds six months of life on average to women dying with an aggressive form of breast cancer. NICE criticised makers Roche for not setting an affordable price, in its updated draft guidance. via Pocket http://ift.tt/1sikOmn